Ambroxol Hydrochloride Sustained Release Capsules

This product is a mucolytic agent that can increase the secretion of serous glands in the respiratory mucosa and reduce the secretion of mucous glands, thereby reducing sputum viscosity, promoting the secretion of pulmonary surfactant, increasing bronchial ciliary movement, and making sputum easier to cough up.

trans-4-[(2-amino-3,5-dibromobenzyl)amino]cyclohexanol hydrochloride

This product is a hard capsule, and the contents are white or off-white spherical pellets.

It is suitable for acute and chronic respiratory diseases, such as acute and chronic bronchitis, bronchial asthma, bronchiectasis, tuberculosis, etc., which cause thick sputum and difficulty in coughing up sputum.

Oral administration after meals. Adults take 75 mg once a day; children take 1.2-1.6 mg/kg/day or reduce the dosage as directed by the doctor.

There may be upper abdominal discomfort, poor appetite, diarrhea, and occasionally rash.

It is contraindicated for those who are allergic to this product.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.

Not yet clear.

Keep tightly closed in a dry place.

25 mg

24 months

China Resources Zizhu Pharmaceutical Co., Ltd.

• Founded in:

  1980-11-26

• Address:

  Building 18, No. 27 Chaoyang North Road, Chaoyang District, Beijing

• Tax NO.:

  91110000101939631P

• Registered Funds:

  660.6396 million yuan

• Website:

  Log in to view

• Email:

  Log in to view